BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6874280)

  • 1. Detection of cytoplasmic S-100 protein in primary and metastatic intraocular melanomas.
    Cochran AJ; Holland GN; Wen DR; Herschman HR; Lee WR; Foos RY; Straatsma BR
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1153-5. PubMed ID: 6874280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors.
    Weiss SW; Langloss JM; Enzinger FM
    Lab Invest; 1983 Sep; 49(3):299-308. PubMed ID: 6310227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of S-100 protein as an aid to the identification of melanocytic tumors.
    Cochran AJ; Wen DR; Herschman HR; Gaynor RB
    Int J Cancer; 1982 Sep; 30(3):295-7. PubMed ID: 6752046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain.
    Kindblom LG; Lodding P; Rosengren L; Baudier J; Haglid K
    Acta Pathol Microbiol Immunol Scand A; 1984 Jul; 92(4):219-30. PubMed ID: 6496075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining techniques of intraocular tumors.
    Kochavi O; Munichor M; Lichtig C; Meyer E
    Ann Ophthalmol; 1992 Sep; 24(9):347-51. PubMed ID: 1471823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunoperoxidase study of S-100 protein in neoplastic cells in serous effusions. Use as a marker for melanoma.
    Pinto MM
    Acta Cytol; 1986; 30(3):240-4. PubMed ID: 3521174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
    Radfar A; Stefanato CM; Ghosn S; Bhawan J
    Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application.
    Nakajima T; Watanabe S; Sato Y; Kameya T; Shimosato Y; Ishihara K
    Cancer; 1982 Sep; 50(5):912-8. PubMed ID: 6807528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
    Mirecka J; Korabiowska M; Schauer A
    Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
    Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
    Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of S-100 protein in melanocytic and neurogenic cutaneous tumors.
    Yambe H; Ishii Y; Tabuchi K; Isobe T; Kikuchi K
    Arch Dermatol Res; 1984; 276(3):160-4. PubMed ID: 6383227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma.
    Kvanta A; Steen B; Seregard S
    Exp Eye Res; 1996 Nov; 63(5):511-8. PubMed ID: 8994354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and quantification of S-100 protein in ocular tissues and fluids from patients with intraocular melanoma.
    Cochran AJ; Holland GN; Saxton RE; Damato BE; Foulds WR; Herschman HR; Foos RY; Straatsma BR; Lee WR
    Br J Ophthalmol; 1988 Nov; 72(11):874-9. PubMed ID: 3207666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
    Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
    Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
    Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
    Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular tumors. A cytopathologic study.
    Scroggs MW; Johnston WW; Klintworth GK
    Acta Cytol; 1990; 34(3):401-8. PubMed ID: 2343699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microphthalmia transcription factor immunohistochemistry: a useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms.
    O'Reilly FM; Brat DJ; McAlpine BE; Grossniklaus HE; Folpe AL; Arbiser JL
    J Am Acad Dermatol; 2001 Sep; 45(3):414-9. PubMed ID: 11511840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous melanoma metastatic to the vitreous cavity.
    Gündüz K; Shields JA; Shields CL; Eagle RC
    Ophthalmology; 1998 Apr; 105(4):600-5. PubMed ID: 9544631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):505-11. PubMed ID: 9066703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.